T
Terns Pharmaceuticals D
D
TERN
5.88000
USD
0.09
(1.55%)
Market Closed
Volume
33,540
EPS
-1
Div Yield
-
P/E
-5
Market Cap
499,440,467
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Terns Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.